Drug & supplement interaction

Ligilactobacillus Salivarius + Omalizumab

Omalizumab brand name: Xolair.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Ligilactobacillus Salivarius and Omalizumab in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.

Know someone taking this? Share
Interaction report

Ligilactobacillus Salivarius and Omalizumab

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Omalizumab and Ligilactobacillus Salivarius in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Ligilactobacillus Salivarius safety at a glance

Ligilactobacillus... overall Use caution Generally well tolerated in healthy people, but caution is advised for those who are seriously ill or immunocompromised.
Pregnancy Possibly Safe When used orally and appropriately. Ligilactobacillus salivarius has been safely used from about 30 weeks' gestation or diagnosis of gestational diabetes until... Read the full pregnancy detail
Breastfeeding Use caution Limited safety data while breastfeeding; check with your doctor first.

Pregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center) — the full detail is in the Special populations card below. Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Omalizumab and Ligilactobacillus Salivarius? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
How we checked

Why No Interaction Is Listed for Omalizumab

Interactions in our licensed database are recorded against drug classes, not just single drug names. Omalizumab is filed under a single classification — immunosuppressants. Ligilactobacillus Salivarius has documented interactions with 1 drug class — the most serious being antibiotic drugs (moderate) — and none of Omalizumab’s classifications are among them.

Classification data comes from our licensed Natural Medicines dataset. A medication can belong to classes beyond those recorded there, so this describes how the check was run — it is not a safety guarantee.

Keep it in perspective

Ligilactobacillus Salivarius Does Interact With Other Medications

Ligilactobacillus Salivarius has 182 moderate known drug interactions in our database — Omalizumab isn’t one of them. If you take anything else, check it against the full list below.

Taking anything else?

Check Another of Your Medications Against Ligilactobacillus Salivarius

Covers the 2,830 medications we’ve checked against Ligilactobacillus Salivarius. Pick one to open its full report.

What to actually watch for

What Ligilactobacillus Salivarius Itself Has Been Linked To

This is not an interaction — nothing below involves Omalizumab. It is the side-effect record for Ligilactobacillus Salivarius on its own, from the licensed Natural Medicines monograph. If something new turns up after you add Ligilactobacillus Salivarius, this list is the first place to look. One entry is worth acting on rather than waiting out — marked below.

  • A higher chance of infection Worth acting on Additional detail

    “Since Ligilactobacillus salivarius preparations contain live and active microorganisms, there is some concern that they might cause pathogenic infection in some patients. Some lactobacilli species have been isolated in cases of bacteremia, sepsis, splenic abscess, endocarditis, necrotizing fasciitis, pancreatic necrosis, and meningoencephalitis.”

    Ligilactobacillus Salivarius · Natural Medicines adverse-effect record, reported in diabetes.

    6 sources cited
    1. 107543. Rossi F, Amadoro C, Gasperi M, Colavita G. Lactobacilli infection case reports in the last three years and safety implications. Nutrients. 2022;14(6):1178. PubMed
    2. 110917. Ranchal P, Gupta R, Goldberg R, A Lobo S, Pascual A, El Khoury MY. Penicillin-sensitive Lactobacillus jensenii bacteremia. Am J Ther 2021;28(2):e250-e252. PubMed
    3. 110918. Grazioli-Gauthier L, Rigamonti E, Leo LA, Martinetti Lucchini G, Lo Priore E, Bernasconi E. Lactobacillus jensenii mitral valve endocarditis: Case report, literature review and new perspectives. IDCases 2022;27:e01401. PubMed
    4. 110920. Toprak NU, Bozan T, Yilmaz S, Buyukbayrak EE, Tigen ET. Polymicrobial bacteremia due to Lactobacillus jensenii and Veillonella montpellierensis in a pregnant patient; case report and review of literature. Anaerobe 2022;75:102576. PubMed
    5. 110921. Chazan B, Raz R, Shental Y, Sprecher H, Colodner R. Bacteremia and pyelonephritis caused by Lactobacillus jensenii in a patient with urolithiasis. Isr Med Assoc J 2008;10(2):164-5.
    6. 112546. Wang HK, Teng LJ, Chen YC, Du SH, Hsueh PR. Lactobacillus salivarius empyema with respiratory failure. J Microbiol Immunol Infect 2017;50(6):923-925. PubMed

Everything above comes from the Natural Medicines adverse-effect record for Ligilactobacillus Salivarius — expand a row for the licensed statement it rests on. We read the ADVERSE REACTIONS section of Omalizumab’s FDA label too, and the two lists don’t meaningfully overlap — which is why no Omalizumab column appears here.

Special populations

Ligilactobacillus Salivarius in Pregnancy & Breastfeeding

Pregnancy Possibly Safe

When used orally and appropriately. Ligilactobacillus salivarius has been safely used from about 30 weeks' gestation or diagnosis of gestational diabetes until delivery.

DISCLAIMER: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice. Patients should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.© 2026 Therapeutic Research Center

Overlapping uses

What Omalizumab Is Prescribed For, and What Ligilactobacillus Salivarius Has Been Studied For

These two come up together because they touch the same health topic — not because they do the same job. Omalizumab is a prescription medicine with approved uses on its FDA label. Ligilactobacillus Salivarius is a supplement: what follows is what researchers have looked at it for, and how strong that evidence is.

Omalizumab is prescribed for: Xolair is used for several allergy-driven conditions. It treats moderate to severe persistent asthma in adults and children 6 and older whose symptoms aren't controlled by inhaled steroids alone and who test positive for a year-round airborne allergen. It is also used as an add-on maintenance treatment for chronic rhinosinusitis with nasal polyps (ongoing sinus inflammation with polyp growths) in adults 18 and older who haven't responded well to nasal corticosteroids. Xolair is also approved to reduce allergic reactions — including anaphylaxis — from accidental food exposure in adults and children aged 1 and older with IgE-mediated food allergy.

Read the rest of what Omalizumab is prescribed for

It must be used alongside strict food avoidance, and it is not a substitute for emergency treatment like epinephrine. Finally, Xolair treats chronic spontaneous urticaria (persistent hives with no identified trigger) in adults and adolescents 12 and older who still have symptoms despite antihistamine treatment.

Ligilactobacillus Salivarius has been studied for:

  • Asthma studied, not established Ligilactobacillus Salivarius has been studied for this. Natural Medicines rates the evidence: Insufficient Reliable Evidence To Rate Read what the research shows

    Ligilactobacillus Salivarius for asthma

    Oral Ligilactobacillus salivarius has only been evaluated in combination with other ingredients; its effect when used alone is unclear.

Effectiveness ratings and the research summaries above are the verbatim record from the Natural Medicines database, which grades evidence from “Effective” down to “Insufficient Reliable Evidence To Rate”. A rating below the top of that scale means researchers have looked at it — not that it works, and never that it can stand in for a prescribed medicine. Do not stop or replace Omalizumab on your own; if you are taking Ligilactobacillus Salivarius for the same health topic, tell your prescriber, especially if the medicine is being adjusted to a target.

Everything else you take

See Every Supplement That Interacts With Omalizumab

This page covers Ligilactobacillus Salivarius only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Omalizumab page lists 53 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Active Hexose Correlated Compound (ahcc) (moderate), Alfalfa (moderate), American Ginseng (moderate), Andrographis (moderate) and Ashwagandha (moderate).

By severity: 52 moderate · 1 minor.

From our pharmacist’s overview on the Omalizumab page

“None of the 53 supplements on file for omalizumab (Xolair) carries a major rating, so this is a list to read with steady attention rather than alarm. Xolair treats allergic asthma and chronic hives by calming part of the immune system, and every entry here pulls the other way: these are immune-stimulating products, echinacea and astrag…”

Reviewed by 2 · Jul 18, 2026

Open the Omalizumab interaction page

How much people look this up

Where Ligilactobacillus Salivarius and Omalizumab Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Ligilactobacillus Salivarius
Top half

#557 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Omalizumab
Steady interest

#1,449 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Ligilactobacillus Salivarius reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 20, 2026. The Ligilactobacillus Salivarius and Omalizumab records this page draws on were last updated July 11, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Ligilactobacillus Salivarius

What is Ligilactobacillus Salivarius?

  • Digestive and gut health
  • Oral and dental health
  • Immune support
  • Vaginal and urinary health
  • General probiotic supplementation

Ligilactobacillus salivarius (formerly called Lactobacillus salivarius) is a probiotic bacterium found naturally in the mouth and gut of humans and animals. People take it to support digestion, oral health, and immunity, but solid human evidence is still limited for most uses. It is generally well tolerated in healthy people, but those with weakened immune systems should check with a doctor first.

Ligilactobacillus salivarius · Lactobacillaceae · Live bacterial cells (probiotic strain) · Capsules, tablets, chewable tablets, powders, and some fortified foods or oral lozenges

An interaction check asks whether these two react with each other — it does not ask whether Ligilactobacillus Salivarius is a good idea for someone in your situation. Here is what our Ligilactobacillus Salivarius record says about it on its own.

Ligilactobacillus Salivarius: dosing

There is no official standardized dose for Ligilactobacillus salivarius. Probiotic doses are usually measured in colony-forming units (CFUs), and the amount varies widely between products.The best approach is to follow the directions on the product label, since doses are tied to the specific strain and formulation.

From our Ligilactobacillus Salivarius monograph — the full record covers uses, side effects and every documented interaction.

Read the full Ligilactobacillus Salivarius monograph & all interactions
Medication

About Omalizumab Injection

What Is Omalizumab Injection Used For?

Brand name: Xolair

Xolair is used for several allergy-driven conditions. It treats moderate to severe persistent asthma in adults and children 6 and older whose symptoms aren't controlled by inhaled steroids alone and who test positive for a year-round airborne allergen. It is also used as an add-on maintenance treatment for chronic rhinosinusitis with nasal polyps (ongoing sinus inflammation with polyp growths) in adults 18 and older who haven't responded well to nasal corticosteroids.

Xolair is also approved to reduce allergic reactions — including anaphylaxis — from accidental food exposure in adults and children aged 1 and older with IgE-mediated food allergy. It must be used alongside strict food avoidance, and it is not a substitute for emergency treatment like epinephrine. Finally, Xolair treats chronic spontaneous urticaria (persistent hives with no identified trigger) in adults and adolescents 12 and older who still have symptoms despite antihistamine treatment.

See full Omalizumab Injection drug information
Keep checking

Other Drugs & Ligilactobacillus Salivarius

Browse every other medication we’ve checked against Ligilactobacillus Salivarius — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
182Moderate
0Minor
2,647No known interaction
Moderate

182 interactions

Showing 60 of 182 moderate interactions — see all 182 on the Ligilactobacillus Salivarius page.

No interaction 2,647 drugs checked — show the list
Evidence & sources

Ligilactobacillus Salivarius References

The 10 references that drive our Ligilactobacillus Salivarius monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Pierce A. The American Pharmaceutical Association Practical Guide to Natural Medicines. New York: The Stonesong Press, 1999:19.
  2. Lindsay KL, Brennan L, Kennelly MA, et al. Impact of probiotics in women with gestational diabetes mellitus on metabolic health: a randomized controlled trial. Am J Obstet Gynecol. 2015;212(4):496.e1-11. PubMed
  3. Fernández L, Cárdenas N, Arroyo R, et al. Prevention of Infectious Mastitis by Oral Administration of Lactobacillus salivarius PS2 During Late Pregnancy. Clin Infect Dis. 2016;62(5):568-573.
  4. Rossi F, Amadoro C, Gasperi M, Colavita G. Lactobacilli infection case reports in the last three years and safety implications. Nutrients. 2022;14(6):1178. PubMed
  5. Ranchal P, Gupta R, Goldberg R, A Lobo S, Pascual A, El Khoury MY. Penicillin-sensitive Lactobacillus jensenii bacteremia. Am J Ther 2021;28(2):e250-e252. PubMed
  6. Grazioli-Gauthier L, Rigamonti E, Leo LA, Martinetti Lucchini G, Lo Priore E, Bernasconi E. Lactobacillus jensenii mitral valve endocarditis: Case report, literature review and new perspectives. IDCases 2022;27:e01401. PubMed
  7. Toprak NU, Bozan T, Yilmaz S, Buyukbayrak EE, Tigen ET. Polymicrobial bacteremia due to Lactobacillus jensenii and Veillonella montpellierensis in a pregnant patient; case report and review of literature. Anaerobe 2022;75:102576. PubMed
  8. Chazan B, Raz R, Shental Y, Sprecher H, Colodner R. Bacteremia and pyelonephritis caused by Lactobacillus jensenii in a patient with urolithiasis. Isr Med Assoc J 2008;10(2):164-5.
  9. Wang HK, Teng LJ, Chen YC, Du SH, Hsueh PR. Lactobacillus salivarius empyema with respiratory failure. J Microbiol Immunol Infect 2017;50(6):923-925. PubMed
  10. García Carretero R, Regodon Dominguez M, Ruiz Bastian M, Lopez Lomba M. Lactobacillus salivarius infection as a postoperative complication after bariatric surgery. Enferm Infecc Microbiol Clin (Engl Ed) 2018;36(1):60-61. DOI

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Ligilactobacillus Salivarius and Omalizumab Together: Common Questions

Is it safe to take Ligilactobacillus Salivarius with Omalizumab?
We do not list a known interaction between Ligilactobacillus Salivarius and Omalizumab. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Are Ligilactobacillus Salivarius and Omalizumab used for the same thing?
They overlap in purpose, which usually means the real question is whether you need both rather than whether they are safe together. This page lists the shared uses and how strong the evidence is for Ligilactobacillus Salivarius in each. That is a conversation for your prescriber, especially if Omalizumab is being adjusted to a target.
How was the Ligilactobacillus Salivarius and Omalizumab combination checked?
Interactions in our licensed database are recorded against drug classes. Omalizumab is filed under 1 classification, and Ligilactobacillus Salivarius has documented interactions with 1 drug class — none of Omalizumab's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Does Ligilactobacillus Salivarius interact with any other medications?
Yes. Ligilactobacillus Salivarius has 182 documented drug interactions in our database — Omalizumab is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does Omalizumab interact with any supplements?
Yes. Omalizumab has documented interactions with 53 supplements in our database — Ligilactobacillus Salivarius is not one of them. The Omalizumab interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Omalizumab and Ligilactobacillus Salivarius?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.